Sign up to save your podcasts
Or
Share Evolving Treatment Landscape for mHSPC: Latest Clinical Data and Implications for Practice
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Evolving Treatment Landscape for mHSPC: Latest Clinical Data and Implications for Practice
Did you know androgen deprivation monotherapy is no longer considered standard of care for metastatic hormone-sensitive prostate cancer (mHSPC) by experts?
Credit available for this activity expires: 11/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001957?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.3
2323 ratings
Did you know androgen deprivation monotherapy is no longer considered standard of care for metastatic hormone-sensitive prostate cancer (mHSPC) by experts?
Credit available for this activity expires: 11/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001957?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
NEJM This Week
321 Listeners
AFP: American Family Physician Podcast
697 Listeners
JAMA Clinical Reviews
495 Listeners
JACC This Week
170 Listeners
Diabetes Core Update
101 Listeners
This Week in Cardiology
886 Listeners
The Bob Harrington Show
13 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
290 Listeners
Frankly Speaking About Family Medicine
263 Listeners
The Curbsiders Internal Medicine Podcast
3,333 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
138 Listeners
Core IM | Internal Medicine Podcast
1,151 Listeners
The Peter Attia Drive
8,916 Listeners
Annals On Call Podcast
196 Listeners
Medicine and the Machine
61 Listeners
Keeping Current
7 Listeners
Cardionerds: A Cardiology Podcast
430 Listeners
The Cribsiders
312 Listeners